PharmaShots | Incisive News in 3 Shots

Subscribe Now

GalXC RNAi technology

Lilly Signs a Global Research and License Collaboration with Dicerna for ~$550M

Lilly Signs a Global Research and License Collaboration with Dicerna for ~$550M

October 29, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us